SLC7A11 and neoplasm: The combination of radiotherapy and immunotherapy downregulates SLC7A11 gene expression, mediated by ATM and IFN-γ induced by DNA damage, resulting in reduced cysteine intake, increased ferroptosis, and enhanced tumor control (Jiang et al., 2021).